What is Glooko?
Glooko operates at the intersection of medical technology and data analytics, providing a comprehensive, intelligent, and connected care platform designed to improve health outcomes for individuals living with chronic conditions. By revolutionizing the connection between patients and their care teams, the platform drives patient engagement and adherence through sophisticated digital therapeutics. Furthermore, Glooko plays a pivotal role in modernizing clinical research by accelerating the speed and efficiency of clinical trials. Its market position is bolstered by a unique ecosystem that integrates seamlessly with various medical devices, making it an indispensable tool for healthcare systems aiming to optimize chronic disease management and patient-centric care delivery.
How much funding has Glooko raised?
Glooko has raised a total of $190.5M across 7 funding rounds:
Angel/Seed
$1M
Series A
$7M
Series B
$16.5M
Series C
$35M
Debt
$1M
Series D
$30M
Series F
$100M
Angel/Seed (2011): $1M with participation from Bill Campbell, Judy Estrin, Vint Cerf, Andy Hertzfeld, Anand Agarawala, Social+Capital, Russel Hirsch, Venky Harinarayan, Xtreme Labs, and Annad Rajarman
Series A (2014): $7M led by The Social+Capital Partnership and Samsung Ventures
Series B (2015): $16.5M supported by The Social + Capital Partnership, Samsung Ventures, Medtronic, and Canaan Capital
Series C (2017): $35M featuring Georgian, Mayo Clinic, Medtronic, Canaan Partners, Insulet, and Samsung NEXT
Debt (2020): $1M backed by PPP
Series D (2021): $30M with participation from Canaan Partners, Insulet, Georgian, Health Catalyst Capital Management, Mayo Clinic, and Novo Nordisk
Series F (2024): $100M led by Georgian and Health Catalyst Capital Management
Key Investors in Glooko
Canaan Partners
Canaan is an early-stage venture capital firm that invests in technology and healthcare companies, backing founders from seed through growth stages in areas such as enterprise software, fintech, consumer, biopharma, and digital health.
Medtronic
Medtronic is a global healthcare technology company that develops and manufactures medical devices, therapies, and digital health solutions to improve patient outcomes through innovative products and services.
Health Catalyst Capital Management
Health Catalyst Capital is a private equity firm that invests in high-growth healthcare information technology and tech-enabled services businesses, aiming to enhance the quality, access, and affordability of care.
What's next for Glooko?
With the successful closure of this latest financing, Glooko is well-positioned to further expand its footprint in the global healthcare market. The strategic capital will likely be deployed to enhance its data-driven insights, scale its digital therapeutics offerings, and deepen its partnerships with major healthcare organizations. As the industry shifts toward value-based care, Glooko's ability to leverage real-world evidence and patient engagement tools will be critical in maintaining its competitive edge. Future growth will likely focus on broadening its therapeutic reach and refining its platform to support more complex clinical workflows, ensuring that the company remains at the forefront of the digital health revolution.
See full Glooko company page
